About this trial
This prospective observational investigation will examine the incidence and progression of cardiologic findings in individuals with OI across different age groups. Cardiopulmonary complications are recognized as major contributors to morbidity and mortality in adults with OI, although life expectancy has significantly improved in recent years due to medical advancements.
By systematically evaluating cardiovascular involvement in this population, the study aims to generate clinically relevant evidence to inform early cardiologic screening strategies and support the development of harmonized and targeted management approaches, ultimately improving clinical practice and the quality of life of individuals living with OI.
Eligibility criteria
Qualifiers
Diagnosis of OI according to the modified Sillence classification (Mortier et al., 2019)
All subjects with OI who attend genetic consultations at the clinic affiliated with the Rare Skeletal Diseases Unit of the IRCCS Rizzoli Orthopaedic Institute (IOR)
Willingness to undergo clinical and instrumental assessments at the IOR
Disqualifiers
Acute upper and/or lower respiratory tract infections at the time of assessment
Cognitive impairment affecting cooperation and the performance of examinations
Trial design
Treatments tested in this trial
- Imaging evaluation, Echocardiography